Skip to main content

Renin Angiotensin Mechanism.

FACTORS AFFECTING PROTEIN DRUG BINDING.

 

FACTORS AFFECTING PROTEIN DRUG BINDING.

  • Different factors that affect plasma protein binding of a drug are as follows,

    • 1) Drug-related factors.

      • a) Physicochemical characteristics of the drug.

      • b) Concentration of the drug in the body.

      • c) Affinity of a drug for a particular binding component.

    • 2) Protein/ tissue related factors:

      • a) Physicochemical characteristics of protein or binding agent.

      • b) Concentration of protein or binding component.

    • 3) Drug interactions:

      • a) Competition between drugs for the binding sites[ Displacement interactions.

      • b) Competition between drug & normal body constituents.

      • c) Allosteric changes in protein molecules.

    • 4) Patient-related factors:

      • a) Age, Sex, Body Weight:

      • b) Intersubject variability.

      • c) Disease states.

  1. Drug Related Factors:

  1. Physicochemical characteristics of the drug:

    • Protein binding is directly related to the lipophilicity of the drug.

    • An increase in lipophilicity increases the extent of binding

    • Drugs bind to specific binding sites as per their nature i.e. Acidic, basic and neutral.

  2. Concentration of the  drug in the body:

    • Alteration in the concentration of a drug substance as well as the  molecules or binding surfaces ultimately brings changes in the binding process.

  3. Affinity of a drug for a particular binding component:

    • Plasma protein binding of a drug depends upon the degree of attraction or affinity the protein molecule or tissues have towards the particular drug molecule.

    • Digoxin has more affinity for cardiac muscle proteins as compared to proteins of skeletal muscles and plasma proteins like HSA.

2) Protein/ tissue related factors:

  1. Physicochemical characteristics of protein or binding agent:

    • Lipoproteins & adipose tissue tend to bind lipophilic drug by 

    • dissolving them in their lipid core.

    • The physiological pH determines the presence of active anionic & cationic groups on the albumin to bind a variety of drugs.

  2. Concentration of protein or binding component:

    • Among the plasma proteins , binding predominantly occurs with  albumin, as it is present in higher concentration in comparison to  other plasma proteins.

    • The amount of several proteins and tissue components available for binding, changes during disease state

3) Drug interactions:

  1. Competition between drugs for the binding sites[ Displacement interactions]:-

    • When two drugs are administered together, one drug displaces another drug from its plasma protein binding site as both drugs have affinity towards the same binding site.

    • The displaced drug concentration in blood rises suddenly, causing adverse effects.

    • e.g. When a patient on Warfarin therapy is given Phenylbutazone, the phenylbutazone displaces Warfarin from its binding site, the free warfarin concentration causes hemorrhagic complications in the patients.

  2. Competition between drug & normal body constituents:-

    • The free fatty acids are known to interact with a no. of drugs that binds primarily to HSA.

    • The free fatty acid level increases in certain physiological, pathological conditions.

  3. Allosteric changes in protein molecule:-

    • This process involves change in the protein structure by the drug or its metabolite thereby modifying its binding capacity of other drugs.

    • e.g. aspirin acetylates albumin thereby modifying its capacity to bind NSAIDs like phenylbutazone

4) Patient-related factors:

  1. Age, Sex, Body Weight:

    • Neonates: Low albumin content: More free drug.

    • Young infants: High dose of Digoxin needed due to large renal clearance.

    • Elderly: Low albumin: So more free drug.

    • Male has more blood as compared to the female.

  2.  Intersubject variability:

    • This happens due to genetic makeup and surrounding of the individual.

  3. Disease states:-

    • Many diseases affect different parameters that can define plasma protein binding, e.g.

      1. In Renal failure there is decreased Albumin content  which causes decrease in binding of acidic drugs; neutral and basic drugs are unaffected

      2. In Hepatic failure there is decreased Albumin content  which causes decrease in binding of acidic drugs; binding of basic drugs remain normal or dependent on AAG levels and neutral drugs are unaffected.

      3. In case of inflammatory conditions like trauma, surgeries etc there are elevated levels of AAG which causes increased binding of basic drugs.

Popular posts from this blog

Rate of Drying Curve.

  Definition Drying is defined as the removal of liquid from a product usually with application of heat. Rate of Drying Curve. Drying process can be divided into three periods Initial Adjustment Period. Constant drying rate period. First falling drying rate period. Second falling rate period. Initial Adjustment Period (A-B): Also called the “ Heating up” period . In this period the substance gets heat and increases in temperature. Drying has not yet started. Constant drying rate period (B-C): During this period the temperature of the solid and the rate of drying remain constant. The moisture evaporating from the surface is replaced by water diffusing from the interior of the solid at a rate equal t o the rate of evaporation.  The moisture content at the end of constant rate (point C) is referred to as the critical moisture content (CMC).  At CMC, dry spots start appearing and drying rate starts falling . First falling drying rate period (C-D): This period is also called the period of

Heat Exchangers and Heat Interchangers.

  In pharmaceutical industries many types of equipments are used for transfer of heat, they can be classified as follows, Heat Exchangers. Heat Interchangers. Heat Exchangers: These devices are used for transferring heat from a fluid (Hot Gas or Steam) to another fluid (Liquid) through a metal wall. Heat Interchangers: These devices are used for transferring heat from a One liquid to another liquid or one gas to another gas through a metal wall. HEAT EXCHANGERS; The equipment used for heat transferring are known as heat exchangers. Some of the processes that involves heat transfer in pharmaceutical industries are: Preparation of starch paste (in steam jacketed kettle). Crystallization. Evaporation. Distillation.  Classification of heat exchangers On the basis of transfer of heat, heat exchangers are classified as: Direct transfer type:  The hot and cold fluids are separated by a metal wall through which the heat is transferred from hot fluid to cold fluid. E.g. shell and tube heater, 

Flash Distillation.

  Principle: When a hot mixture is allowed to enter from a high-pressure zone into a low pressure zone, the entire liquid mixture is suddenly vaporized. This process is known as flash vaporization .  During this process, the chamber is cooled.  The less volatile fraction is condensed and the more volatile component remains in the vapor phase .  This process requires time, hence liquid and vapor are kept in intimate contact until equilibrium is achieved. Flash distillation is also called equilibrium distillation because separation of two liquids takes place when liquid and vapor phases are at equilibrium. Equipment used for Flash Distillation: Construction: It consists of a pump, which is connected to a feed reservoir.  Pumps help in pumping the feed into the heating chamber.  The heating chamber is heat supplied by steam.  The other end of the pipe is directly introduced into the vapor-liquid separator through a reducing valve.  The vapor outlet is provided at the top of the separato